P4–248: Neuroparin (C3), an orally administered low molecular weight glycosaminoglycan, improves behavior and ameliorates amyloid–beta pathology in a double transgenic mouse model of Alzheimer's disease (APPSwe, PSEN1dE9)
Year: 2006
Type: article
Source: Alzheimer s & Dementia
Authors: John M. Lee, Casey N. Cook, Matthew J. Hejna, Susan O. McGuire
Institution: Loyola University Chicago
Language: English
Subfield: Physiology (medical)
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W3023384591